Vetoquinol: down after sales update
"Business is not comparable with the previous year, given the overstocking effect at our customers in the first quarter of 2023, linked to the anticipation of the implementation of the new ERP in April 2023", the animal health group nevertheless states.
Stifel is nevertheless reducing its EPS estimates by 8% for 2024 and 7% for 2025, to reflect higher purchasing and personnel costs. Stifel remains 'Hold' on the stock, while lowering its target price from €104 to €95.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction